ProCap director exit triggers Nasdaq noncompliance
ProCap Financial, Inc. reported that director William H. Miller IV has resigned from its Board of Directors and from the Audit, Compensation, Governance, and Treasury Committees, effective January 20, 2026.
Rhea-AI Filing Summary
ProCap Financial, Inc. reported that director William H. Miller IV has resigned from its Board of Directors and from the Audit, Compensation, Governance, and Treasury Committees, effective January 20, 2026. The company states that his resignation was not due to any dispute or disagreement regarding its operations, policies, or practices.
Because of this departure, ProCap notified Nasdaq on January 22, 2026 that it no longer complies with Nasdaq Listing Rule 5605(c)(2)(A), which requires at least three independent audit committee members, and Listing Rule 5605(b), which requires a majority of independent directors on the Board. The Board now has two independent directors, two non‑independent directors, and one vacant seat intended for a new independent director. ProCap plans to use Nasdaq’s cure periods under Listing Rules 5605(c)(4)(B) and 5605(b)(1)(A) and is actively searching for an independent director to restore compliance.
Positive
- None.
Negative
- None.
Insights
Director exit leaves ProCap temporarily out of Nasdaq independence compliance, with plans to cure via a new independent board member.
The resignation of William H. Miller IV removes an independent director from both the Board and key committees, including the Audit Committee. The company notes his departure is not due to any disagreement on operations, policies, or practices, which helps limit concerns about internal conflict, but it still creates a governance gap.
ProCap has disclosed to Nasdaq that it no longer meets Listing Rule 5605(c)(2)(A) for audit committee size and independence, nor the Board independence requirement in Listing Rule 5605(b). The Board currently consists of two independent and two non‑independent directors with one vacant seat. The company states it intends to rely on the cure periods under Rules 5605(c)(4)(B) and 5605(b)(1)(A) while it searches for an independent director, so the practical impact will hinge on how quickly that appointment is completed and accepted by Nasdaq.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did William H. Miller IV resign from ProCap Financial (BRR)?
How did the director resignation affect ProCap Financials Nasdaq compliance?
What is the current composition of ProCap Financials Board after the resignation?
How does ProCap Financial plan to regain compliance with Nasdaq Listing Rules?
Does ProCap Financial link the directors resignation to any disagreement with the company?
Which ProCap Financial board committees were affected by the resignation?
AI-generated analysis. How Rhea-AI works. Not financial advice.